Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374M
-
Number of holders
-
306
-
Total 13F shares, excl. options
-
218M
-
Shares change
-
+16.3M
-
Total reported value, excl. options
-
$6.51B
-
Value change
-
+$539M
-
Put/Call ratio
-
1.04
-
Number of buys
-
134
-
Number of sells
-
-158
-
Price
-
$29.92
Significant Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q4 2019
416 filings reported holding BHC - Bausch Health Companies Inc. - Common Shares, No Par Value as of Q4 2019.
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) has 306 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 218M shares
of 374M outstanding shares and own 58.18% of the company stock.
Largest 10 shareholders include FIL Ltd (26.9M shares), PAULSON & CO. INC. (20.8M shares), ValueAct Holdings, L.P. (17.9M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (16.6M shares), RENAISSANCE TECHNOLOGIES LLC (12.5M shares), VANGUARD GROUP INC (9.77M shares), GOLDENTREE ASSET MANAGEMENT LP (7.16M shares), Slate Path Capital LP (5.58M shares), BANK OF MONTREAL /CAN/ (5.37M shares), and Epoch Investment Partners, Inc. (4.78M shares).
This table shows the top 306 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.